Experience

Davis Polk advised Arcos Dorados Holdings Inc. in connection with the exchange of approximately $131.5 million aggregate principal amount of its 6.625% senior notes due 2023 for its 5.785%…

Davis Polk advised Smith & Nephew plc in connection with the establishment of a WKSI shelf and its debut SEC-registered shelf takedown of $1 billion aggregate principal amount of 2.032%…

Davis Polk advised the underwriters on an SEC-registered offering by Baidu, Inc. of its $650 million 1.720% notes due 2026 and $300 million 2.375% notes due 2030. Baidu, Inc. is a leading…

Davis Polk advised the dealer managers in connection with Empresa Eléctrica Angamos SpA’s cash tender offer for up to the outstanding $388 million aggregate principal amount of its 4.875%…

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S offering of $400 million aggregate principal amount of 2.807% senior notes due 2050 by…

Davis Polk advised BiondVax Pharmaceuticals Ltd. in connection with its registered at-the-market offering of shares of its American depositary shares for up to a maximum offering price of …

Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by Fresnillo plc of 4.250% senior notes due 2050 in the aggregate amount of $850…

Davis Polk advised Boqii Holding Limited on its SEC-registered initial public offering of 7,000,000 American depositary shares. Each ADS represents 0.75 Class A ordinary share of Boqii…

Davis Polk advised the underwriters in connection with an offering by Kemper Corporation of $400 million aggregate principal amount of its 2.400% senior notes due 2030. Kemper…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €6.25 billion aggregate principal amount of notes by Medtronic Global…